Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 22nd July 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD reports drug supply problems
The VMD has revealed that there are currently supply problems with a number of veterinary products. (Stock photo)
Directorate provides advice on alternative products 

The Veterinary Medicines Directorate (VMD) has revealed there are currently supply problems with a number of veterinary products, including leptospirosis vaccines for cattle and local anaesthetic products containing procaine hydrochloride.

Supply problems exist for the following products:

Vaccines for Leptospira hardjo and Leptospira borgpetersenii
There are supply issues with two leptospirosis vaccines authorised in the UK for use in cattle. Supply problems are expected to be resolved in October 2019. In the meantime, the VMD is accepting applications to import an EU alternative, BioBos L. injection suspension for cattle, which is licensed in the Czech Republic, and Spirovac, which is licensed in the USA.

Local anaesthetic products containing procaine hydrochloride
VMD said it is aware of UK availability issues with some of these products. Information on authorised products are available on the VMD’s product information database. Suppliers have advised that the UK authorised Pronestesic 40mg/ml / 0.036mg/ml Solution for Injection for Horses, Cattle, Pigs and Sheep, is available to meet present demand.

Viper Venom Antiserum for veterinary use (adder bite antivenom)
There are no viper venom antiserums licensed in the UK for treating adder bites in animals. VMD accepts applications to import European Viper Antiserum from Biomed (Poland) and the Institute of Immunology, Zagreb (Croatia). VMD said anyone wishing to import should contact the manufacturer before submitting an application to ensure they can supply the quantity needed.

In urgent cases, antivenom may be supplied, purchased and used prior to the special treatment certificate being obtained from the VMD.

ACP injection 10mg/ml solution for injection
This product is indicated for anaesthetic premedication, tranquillisation and sedation in horses. It is not known when stocks will be available. Applications are currently accepted to import this product for use in horses only. Two EU alternatives are available - Calmivet solution for injection (5mg/ml) and Vetranquil 1% solution for injection (10mg/ml).


For information on prescribing under the cascade, visit the VMD’s website.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.